el-Hazmi M A, Warsy A S, al-Swailem A R
Department of Medical Biochemistry, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Hemoglobin. 1995;19(6):353-60. doi: 10.3109/03630269509005827.
The beta-thalassemias are a heterogeneous group with respect to molecular pathogenesis, and different populations and ethnic groups differ with respect to the predominating mutations. This variable spectrum of beta-thalassemia mutations has resulted in extensive studies in each population and ethnic group to identify the major mutations. In this study we investigated the prevalence of 14 mutations in 253 beta-thalassemia patients drawn from eight Arab countries (i.e. Jordan, Egypt, Syria, Lebanon, Yemen, and Saudi Arabia), living in Saudi Arabia and attending Ministry of Health hospitals. The mutations investigated included IVS-I-110 (G-->A), IVS-II-1 (G-->A), IVS-I-5 (G-->C), codon 39 (C-->T), IVS-I-1 (G-->A), frameshift at codons 8/9 (+G), frameshift at codons 41/42 (-TTCT), codon 15 (TGG-->TAG), IVS-I-6 (T-->C), frameshift at codon 16 (-C), IVS-II-745 (C-->G), codon 6(-A), IVS-I, 3' end (-25 bp), and Cap +1 (A-->C). The most frequently encountered mutations were IVS-I-110 and IVS-II-1 which were identified in the population of each Arab country. The IVS-I-1 and IVS-II-745 mutations were encountered in Jordanians, Egyptians, and Syrians. The IVS-I-5, codon 39, codon 6, IVS-I, 3' end (-25 bp), and Cap +1 mutations were encountered only in Saudis and not in other Arabs, except codon 39 which was present in the Syrians and Lebanese. Other mutations were generally rare and not specific to any Arab ethnic group. This paper presents preliminary data on the prevalence of 14 mutations in the Arab populations and shows wide variation in the molecular basis of beta-thalassemia in different Arab ethnic groups. Further detailed studies to identify the entire spectrum of beta-thalassemia mutations are stressed.
β地中海贫血在分子发病机制方面是一个异质性群体,不同人群和种族在主要突变方面存在差异。β地中海贫血突变的这种可变谱导致了对每个群体和种族进行广泛研究以确定主要突变。在本研究中,我们调查了来自八个阿拉伯国家(即约旦、埃及、叙利亚、黎巴嫩、也门和沙特阿拉伯)、居住在沙特阿拉伯并在卫生部医院就诊的253例β地中海贫血患者中14种突变的发生率。所研究的突变包括IVS-I-110(G→A)、IVS-II-1(G→A)、IVS-I-5(G→C)、密码子39(C→T)、IVS-I-1(G→A)、密码子8/9处移码(+G)、密码子41/42处移码(-TTCT)、密码子15(TGG→TAG)、IVS-I-6(T→C)、密码子16处移码(-C)、IVS-II-745(C→G)、密码子6(-A)、IVS-I 3'端(-25 bp)和帽+1(A→C)。最常遇到的突变是IVS-I-110和IVS-II-1,在每个阿拉伯国家的人群中都有发现。IVS-I-1和IVS-II-745突变在约旦人、埃及人和叙利亚人中出现。IVS-I-5、密码子39、密码子6、IVS-I 3'端(-25 bp)和帽+1突变仅在沙特人中出现,在其他阿拉伯人中未出现,除了密码子39在叙利亚人和黎巴嫩人中也有。其他突变通常很少见,且并非任何阿拉伯种族所特有。本文提供了阿拉伯人群中14种突变发生率的初步数据,并显示了不同阿拉伯种族中β地中海贫血分子基础的广泛差异。强调需要进一步进行详细研究以确定β地中海贫血突变的完整谱。